Publications by authors named "Matt Anderson"

Claim this Profile
A
A method for measuring closed-loop latency in gaze-contingent rendering without extra equipment.
Matt D Anderson, Emily A Cooper, Jorge Otero-Millan

Behav Res Methods· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and pharmacokinetics of single and multiple ascending doses of zavegepant nasal spray in healthy adults from two phase 1 randomized, placebo-controlled trials.
Richard Bertz, Mary Donohue, Jennifer Madonia, Rajinder Bhardwaj, Kyle T Matschke, Matt S Anderson

Headache· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferences and Feasibility of Long-Acting Technologies for the Treatment of Hepatitis C Virus: A Survey of Patients in Diverse Low- and Middle-Income Countries.
Renae Furl, Kimberly K Scarsi, Harlan Sayles, Matt Anderson, Joelle Dountio Ofimboudem

J Viral Hepat· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of pharmacokinetic and pharmacodynamic interactions between zavegepant and sumatriptan: A phase 1, randomized, placebo-controlled study in healthy adults.
Rajinder Bhardwaj, Mary K Donohue, Jennifer Madonia, Kyle Matschke, Matt S Anderson

Headache· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Double-Blind, Placebo-Controlled, Short-Term Monotherapy Study of MK-6186, an HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor, in Treatment-Naïve HIV-Infected Participants.
Dirk Schürmann, Andreas Hüser, Frieder Pfäfflin, Caroline Cilissen, Inge De Lepeleire, Matt S Anderson

AIDS Res Hum Retroviruses· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deconvoluting zavegepant drug-drug interactions: A phase I study to evaluate the effects of rifampin and itraconazole on zavegepant pharmacokinetics.
Rajinder Bhardwaj, Jo Ann Malatesta, Jennifer Madonia, Matt S Anderson, Beth Morris

Clin Transl Sci· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mass balance and pharmacokinetic characterization of zavegepant in healthy male subjects.
Rajinder Bhardwaj, Mary Donohue, Jennifer Madonia, Matt S Anderson, Kyle Matschke

Clin Transl Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concentration-QTc and cardiac safety analysis of single and multiple zavegepant nasal spray doses in healthy participants to support approval.
Jim H Hughes, Richard Bertz, Rajinder Bhardwaj, Mary K Donohue, Jennifer Madonia, Matt S Anderson

CPT Pharmacometrics Syst Pharmacol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioequivalence of rimegepant, a small molecule CGRP receptor antagonist, administered as an oral tablet, a sublingual orally disintegrating tablet, and a supralingual orally disintegrating tablet: two phase 1 randomized studies in healthy adults.
Robert Croop, Rajinder Bhardwaj, Matt S Anderson, Kyle T Matschke, Jennifer Hould

Cephalalgia· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The time-course of real-world scene perception: Spatial and semantic processing.
Matt D Anderson, James H Elder, Erich W Graf, Wendy J Adams

iScience· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Antiseizure Medication Administration on Mortality and Early Posttraumatic Seizures in Critically Ill Older Adults with Traumatic Brain Injury.
Adam C Glaser, John H Kanter, Pablo Martinez-Camblor, Andreas Taenzer, Matt V Anderson

Neurocrit Care· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P-Glycoprotein and Breast Cancer Resistance Protein Transporter Inhibition by Cyclosporine and Quinidine on the Pharmacokinetics of Oral Rimegepant in Healthy Subjects.
Rajinder Bhardwaj, Julie L Collins, Joseph Stringfellow, Jennifer Madonia, Matt S Anderson

Clin Pharmacol Drug Dev· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Milk and Plasma Pharmacokinetics of Single-Dose Rimegepant 75 mg in Healthy Lactating Women.
Teresa E Baker, Robert Croop, Lisa Kamen, Patty Price, David A Stock, Matt S Anderson

Breastfeed Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PET tracer [C]MK-6884 quantifies M4 muscarinic receptor in rhesus monkeys and patients with Alzheimer's disease.
Wenping Li, Yuchuan Wang, Talakad G Lohith, Zhizhen Zeng, Ling Tong, Matt S Anderson

Sci Transl Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Category systems for real-world scenes.
Matt D Anderson, Erich W Graf, James H Elder, Krista A Ehinger, Wendy J Adams

J Vis· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No meaningful drug interactions with doravirine, lamivudine and tenofovir disoproxil fumarate coadministration.
Matt S Anderson, Jocelyn Gilmartin, Li Fan, Ka Lai Yee, Walter K Kraft

Antivir Ther· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pharmacokinetic Bioequivalence Study Comparing Sublingual Riluzole (BHV-0223) and Oral Tablet Formulation of Riluzole in Healthy Volunteers.
Irfan Qureshi, Meghan Lovegren, Victoria Wirtz, Richard Larouche, Mario Tanguay, Matt S Anderson

Clin Pharmacol Drug Dev· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doravirine and the Potential for CYP3A-Mediated Drug-Drug Interactions.
Sauzanne G Khalilieh, Ka Lai Yee, Rosa I Sanchez, Li Fan, Matt S Anderson

Antimicrob Agents Chemother· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of the absorption, distribution, metabolism, excretion and mass balance of doravirine, a non-nucleoside reverse transcriptase inhibitor in humans.
Rosa I Sanchez, Kerry L Fillgrove, Ka Lai Yee, Yuexia Liang, Bing Lu, Matt S Anderson

Xenobiotica· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disruptive coloration and binocular disparity: breaking camouflage.
Wendy J Adams, Erich W Graf, Matt Anderson

Proc Biol Sci· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No Pharmacokinetic Drug-Drug Interaction Between Prasugrel and Vorapaxar Following Multiple-Dose Administration in Healthy Volunteers.
Matt S Anderson, Teddy Kosoglou, Paul Statkevich, Jing Li, Jennifer Rotonda

Clin Pharmacol Drug Dev· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Single and Multiple Doses of Rifampin on the Pharmacokinetics of Doravirine in Healthy Subjects.
Ka Lai Yee, Sauzanne G Khalilieh, Rosa I Sanchez, Rachael Liu, Matt S Anderson

Clin Drug Investig· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir.
Matt S Anderson, Sauzanne Khalilieh, Ka Lai Yee, Rachael Liu, Li Fan

Clin Pharmacokinet· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir.
Matt S Anderson, Sauzanne Khalilieh, Ka Lai Yee, Rachael Liu, Li Fan

Clin Pharmacokinet· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled, short-term monotherapy study of doravirine in treatment-naive HIV-infected individuals.
Dirk Schürmann, Christian Sobotha, Jocelyn Gilmartin, Martine Robberechts, Inge De Lepeleire, Matt S Anderson

AIDS· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis